Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT06091085
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA
Not Applicable
Recruiting
- Conditions
- OSA
- Interventions
- Other: Sham CO2Other: Dynamic CO2
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT06091098
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT06086275
- Locations
- 🇺🇸
Brigham and Women's hospital, Boston, Massachusetts, United States
AGE SELF CARE: Promoting Healthy Aging Through a Group Visit Program
Not Applicable
Completed
- Conditions
- Frailty SyndromeFrail Elderly SyndromeFrailtyAging
- Interventions
- Behavioral: AGE SELF CARE group visit program
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT06079762
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
Recruiting
- Conditions
- Overweight and Obesity
- Interventions
- Diagnostic Test: 24-hour ambulatory blood pressureDietary Supplement: Liberal salt diet
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06069622
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Social Norms, Messengers, and Processing Fluency to Increase Hypertension Medication Adherence
Not Applicable
Completed
- Conditions
- HypertensionMedication Adherence
- Interventions
- Behavioral: Processing fluencyBehavioral: ScorecardBehavioral: Social normsBehavioral: Messenger effects
- First Posted Date
- 2023-10-04
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 65177
- Registration Number
- NCT06066541
- Locations
- 🇺🇸
Humana, Inc., Louisville, Kentucky, United States
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors with Fluciclovine PET/CT
Phase 1
Recruiting
- Conditions
- Metastatic Prostate Neuroendocrine CarcinomaAdvanced Prostate CancerMetastatic Prostate Cancer
- Interventions
- Device: PET/CT
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06062745
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Brigham and Womens Hospital, Boston, Massachusetts, United States
Serial Brain MRI in Hospitalized Preterm Infants
Not Applicable
Active, not recruiting
- Conditions
- Preterm Birth Complication
- Interventions
- Other: Reference/ Standard of care
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06052865
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Care Transitions App for Patients With Multiple Chronic Conditions
Not Applicable
Not yet recruiting
- Conditions
- Chronic Kidney DiseasesHeart FailureCongestive Heart FailureDiabetesDiabetes Mellitus
- Interventions
- Behavioral: Care Transitions App
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 798
- Registration Number
- NCT06051058
Diabetes Remote Intervention to improVe Use of Evidence-based Medications
Phase 4
Completed
- Conditions
- DiabetesCardiovascular Diseases
- Interventions
- Drug: SGLT2 inhibitor, GLP-1 RABehavioral: Education-First
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06046560
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath